Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes

Title:	Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes
Authors:	Cortellini, A.^{Aff1, Aff2, IDs1209401902193w_cor1}; Leonetti, A.^Aff3; Catino, A.^Aff4; Pizzutillo, P.^Aff4; Ricciuti, B.^Aff5; De Giglio, A.^Aff5; Chiari, R.^Aff6; Bordi, P.^Aff3; Santini, D.^Aff7; Giusti, R.^Aff8; De Tursi, M.^Aff9; Brocco, D.^Aff10; Zoratto, F.^Aff11; Rastelli, F.^Aff12; Citarella, F.^Aff7; Russano, M.^Aff7; Filetti, M.^Aff8; Marchetti, P.^{Aff8, Aff13}; Berardi, R.^Aff14; Torniai, M.^Aff14; Cortinovis, D.^Aff15; Sala, E.^Aff15; Maggioni, C.^Aff15; Follador, A.^Aff16; Macerelli, M.^Aff16; Nigro, O.^Aff17; Tuzi, A.^Aff17; Iacono, D.^Aff18; Migliorino, M. R.^Aff18; Banna, G.^Aff19; Porzio, G.^{Aff1, Aff2}; Cannita, K.^Aff2; Ferrara, M. G.^{Aff20, Aff21}; Bria, E.^{Aff20, Aff21}; Galetta, D.^Aff4; Ficorella, C.^{Aff1, Aff2}; Tiseo, M.^{Aff3, Aff22}
Source:	Clinical and Translational Oncology. 22(6):844-851
Database:	Springer Nature Journals